subject: CHEBI:61080

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C0963679

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma

tested_intervention: unsure


subject: UMLS:C0963679

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: UMLS:C0963679

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C0963679


subject: PUBCHEM.COMPOUND:71080313

subject_name: Volasertib


subject: PUBCHEM.COMPOUND:71080313


subject: PUBCHEM.COMPOUND:71080313


subject: PUBCHEM.COMPOUND:71080313


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Urinary Urgency

tested_intervention: yes


subject: CHEBI:31355

subject_name: Carboplatin

object_name: neurofibromatosis 1


subject: CHEBI:31355

object_name: neurofibromatosis type 1


subject: CHEBI:9984

subject_name: vincaleukoblastine sulfate


subject: CHEBI:9984


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: UMLS:C3273366

object_name: Renal cell carcinoma recurrent


subject: UMLS:C3273366

object_name: Renal cancer recurrent


subject: UMLS:C3273366

object_name: adult glioblastoma


subject: UMLS:C3273366

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C3273366

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C3273366

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C3273366

object_name: Recurrent Lip Basal Cell Carcinoma


subject: UMLS:C3273366

object_name: Adult Giant Cell Glioblastoma


subject: UMLS:C3273366

object_name: tongue cancer


subject: UMLS:C3273366

object_name: tongue carcinoma


subject: UMLS:C3273366

object_name: Recurrent Rectal Cancer


subject: UMLS:C3273366

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UMLS:C3273366

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UMLS:C3273366

object_name: stage IVA rectal cancer


subject: UMLS:C3273366

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UMLS:C3273366

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UMLS:C3273366

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UMLS:C3273366

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C3273366

object_name: Oropharyngeal cancer recurrent


subject: UMLS:C3273366

object_name: stage IVA colon cancer


subject: UMLS:C3273366

object_name: Stage IVA Colon Cancer AJCC v7


subject: UMLS:C3273366

object_name: Stage IVA Colon Cancer AJCC v8


subject: UMLS:C3273366

object_name: stage IVB colon cancer


subject: UMLS:C3273366

object_name: Stage IVB Colon Cancer AJCC v7


subject: UMLS:C3273366

object_name: Stage IVB Colon Cancer AJCC v8


subject: UMLS:C3273366

object_name: Colon cancer recurrent


subject: UMLS:C3273366

object_name: Carcinoma larynx recurrent


subject: UMLS:C3273366

object_name: Nasopharyngeal cancer recurrent


subject: UMLS:C3273366

object_name: Relapsed Hypopharynx Carcinoma


subject: UMLS:C3273366

object_name: Malignant neoplasm of hypopharynx recurrent


subject: UMLS:C3273366

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C3273366

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C3273366

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C3273366

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C3273366


subject: UMLS:C3273366

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: UMLS:C3273366

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UMLS:C3273366

object_name: male breast carcinoma


subject: UMLS:C3273366

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UMLS:C3273366

object_name: Recurrent Sinonasal Carcinoma


subject: UMLS:C3273366

object_name: Recurrent Lip and Oral Cavity Carcinoma


subject: UMLS:C3273366

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3273366

object_name: stage IV pancreatic cancer


subject: UMLS:C3273366

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C3273366

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C3273366

object_name: Carcinoma breast stage IV


subject: UMLS:C3273366

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3273366

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3273366

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C3273366

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: UMLS:C3273366

object_name: stage IVB salivary gland cancer


subject: UMLS:C3273366

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C3273366

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: UMLS:C3273366

object_name: stage IVA salivary gland cancer


subject: UMLS:C3273366

object_name: stage IVC salivary gland cancer


subject: UMLS:C3273366

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: UMLS:C3273366

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C3273366

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3273366

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3273366

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3273366

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3273366

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C3273366

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C3273366

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C3273366

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3273366

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3273366

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C3273366

object_name: Recurrent Adult Brain Neoplasm


subject: UMLS:C3273366

object_name: Adult Gliosarcoma


subject: CHEBI:49140

object_name: Renal cell carcinoma recurrent


subject: CHEBI:49140

object_name: Renal cancer recurrent


subject: CHEBI:49140

object_name: adult glioblastoma


subject: CHEBI:49140

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:49140

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:49140

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:49140

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:49140

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:49140

object_name: tongue cancer


subject: CHEBI:49140

object_name: tongue carcinoma


subject: CHEBI:49140

object_name: Recurrent Rectal Cancer


subject: CHEBI:49140

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:49140

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:49140

object_name: stage IVA rectal cancer


subject: CHEBI:49140

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:49140

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:49140

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:49140

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:49140

object_name: Oropharyngeal cancer recurrent


subject: CHEBI:49140

object_name: stage IVA colon cancer


subject: CHEBI:49140

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:49140

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:49140

object_name: stage IVB colon cancer


subject: CHEBI:49140

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:49140

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:49140

object_name: Colon cancer recurrent


subject: CHEBI:49140

object_name: Carcinoma larynx recurrent


subject: CHEBI:49140

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:49140

object_name: Relapsed Hypopharynx Carcinoma


subject: CHEBI:49140

object_name: Malignant neoplasm of hypopharynx recurrent


subject: CHEBI:49140

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:49140

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:49140

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:49140

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:49140


subject: CHEBI:49140

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:49140

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:49140

object_name: male breast carcinoma


subject: CHEBI:49140

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:49140

object_name: Recurrent Sinonasal Carcinoma


subject: CHEBI:49140

object_name: Recurrent Lip and Oral Cavity Carcinoma


subject: CHEBI:49140

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:49140

object_name: stage IV pancreatic cancer


subject: CHEBI:49140

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:49140

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:49140

object_name: Carcinoma breast stage IV


subject: CHEBI:49140

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:49140

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:49140

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:49140

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49140

object_name: stage IVB salivary gland cancer


subject: CHEBI:49140

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:49140

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49140

object_name: stage IVA salivary gland cancer


subject: CHEBI:49140

object_name: stage IVC salivary gland cancer


subject: CHEBI:49140

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49140

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:49140

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:49140

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:49140

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:49140

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:49140

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:49140

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:49140

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:49140

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:49140

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:49140

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:49140

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:49140

object_name: Adult Gliosarcoma


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: Renal cell carcinoma recurrent


subject: CHEBI:31617

object_name: Renal cancer recurrent


subject: CHEBI:31617

object_name: adult glioblastoma


subject: CHEBI:31617

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:31617

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:31617

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:31617

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:31617

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:31617

object_name: tongue cancer


subject: CHEBI:31617

object_name: tongue carcinoma


subject: CHEBI:31617

object_name: Recurrent Rectal Cancer


subject: CHEBI:31617

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:31617

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:31617

object_name: stage IVA rectal cancer


subject: CHEBI:31617

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:31617

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:31617

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:31617

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:31617

object_name: Oropharyngeal cancer recurrent


subject: CHEBI:31617

object_name: stage IVA colon cancer


subject: CHEBI:31617

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:31617

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:31617

object_name: stage IVB colon cancer


subject: CHEBI:31617

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:31617

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:31617

object_name: Colon cancer recurrent


subject: CHEBI:31617

object_name: Carcinoma larynx recurrent


subject: CHEBI:31617

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:31617

object_name: Relapsed Hypopharynx Carcinoma


subject: CHEBI:31617

object_name: Malignant neoplasm of hypopharynx recurrent


subject: CHEBI:31617

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:31617

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:31617

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:31617

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:31617


subject: CHEBI:31617

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:31617

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:31617

object_name: male breast carcinoma


subject: CHEBI:31617

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:31617

object_name: Recurrent Sinonasal Carcinoma


subject: CHEBI:31617

object_name: Recurrent Lip and Oral Cavity Carcinoma


subject: CHEBI:31617

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:31617

object_name: stage IV pancreatic cancer


subject: CHEBI:31617

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:31617

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:31617

object_name: Carcinoma breast stage IV


subject: CHEBI:31617

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:31617

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:31617

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:31617

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:31617

object_name: stage IVB salivary gland cancer


subject: CHEBI:31617

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:31617

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:31617

object_name: stage IVA salivary gland cancer


subject: CHEBI:31617

object_name: stage IVC salivary gland cancer


subject: CHEBI:31617

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:31617

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:31617

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:31617

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:31617

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:31617

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:31617

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:31617

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:31617

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:31617

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:31617

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:31617

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:31617

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:31617

object_name: Adult Gliosarcoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: chronic leukemia


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:133021

subject_name: Venetoclax

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:133021


subject: UNII:8Z28M5SX0X

subject_name: Zandelisib


subject: UNII:8Z28M5SX0X


subject: UMLS:C5907978

subject_name: Alpha-PD1/IL2 Fusion Protein AWT020

object_name: Advanced cancer


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic neuroendocrine carcinoma


subject: CHEBI:72317

object_name: Metastatic small cell carcinoma


subject: CHEBI:72317

object_name: Metastatic Large Cell Neuroendocrine Carcinoma


subject: CHEBI:72317

object_name: Metastatic Neuroendocrine Neoplasm


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C5557645

subject_name: Pulocimab

object_name: Childhood Solid Neoplasm


subject: UMLS:C5557645

object_name: Adult Solid Neoplasm


subject: UMLS:C5557645

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:521267

subject_name: (R)-Carvotanacetone

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:521267

object_name: periodontitis


subject: PUBCHEM.COMPOUND:521267

object_name: gingivitis


subject: CHEBI:50742

subject_name: cyproterone


subject: CHEBI:50742


subject: CHEBI:50742


subject: CHEBI:15365

subject_name: Aspirin

object_name: HIV infection


subject: CHEBI:39548

subject_name: Atorvastatin


subject: PUBCHEM.COMPOUND:21937662

subject_name: Isavuconazole

object_name: aspergillosis


subject: PUBCHEM.COMPOUND:21937662

object_name: Invasive fungal infection


subject: UMLS:C4733650

subject_name: Prodrug APX001

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4733650

object_name: acute myeloid leukemia


subject: UMLS:C3180953

object_name: endogenous depression


subject: UMLS:C3180953

object_name: major depressive disorder


subject: CHEBI:76016

subject_name: Vortioxetine


subject: CHEBI:76016


subject: CHEBI:9150

subject_name: Simvastatin

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:6801

subject_name: Metformin

object_name: type 1 diabetes mellitus


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: glioma


subject: UMLS:C0919079

object_name: malignant glioma


subject: UMLS:C0919079

object_name: adult oligodendroglioma


subject: UMLS:C0919079

object_name: oligodendroglioma


subject: UMLS:C0919079

object_name: childhood oligodendroglioma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: nervous system disorder


subject: CHEBI:91327

subject_name: Tivozanib

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:91327

object_name: clear cell renal carcinoma


subject: CHEBI:91327

object_name: renal cell adenocarcinoma


subject: UMLS:C2830131


subject: UMLS:C2830131


subject: UMLS:C2830131


subject: UMLS:C2830131

object_name: renal cell carcinoma


subject: UMLS:C3896610

subject_name: Serum-derived Bovine Immunoglobulin Protein Isolate

object_name: ulcerative colitis


subject: UMLS:C3896610

object_name: inflammatory bowel disease 1


subject: UMLS:C3896610

object_name: inflammatory bowel disease


subject: UMLS:C3896610

object_name: Crohn disease


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human

object_name: Congenital Bleeding Disorder


subject: UMLS:C0593103

subject_name: Novoseven


subject: PR:000007301

subject_name: coagulation factor VII


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: HMDB:HMDB0248508

subject_name: Apelin

object_name: type 2 diabetes mellitus


subject: HMDB:HMDB0248508

object_name: cardiovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL4650373

subject_name: APELIN


subject: CHEMBL.COMPOUND:CHEMBL4650373


subject: UMLS:C0445115

subject_name: Normal saline


subject: UMLS:C0445115


subject: GTOPDB:1994

subject_name: relaxin


subject: GTOPDB:1994


subject: CHEMBL.COMPOUND:CHEMBL2107882

subject_name: RELAXIN


subject: CHEMBL.COMPOUND:CHEMBL2107882


subject: UMLS:C0035031

subject_name: Relaxin


subject: UMLS:C0035031


subject: CHEBI:478164

subject_name: Cefepime

object_name: Wound Infection


subject: CHEBI:478164

object_name: Wound Infection, CTCAE


subject: CHEBI:3515

subject_name: Cefuroxime


subject: CHEBI:3515


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: UNII:6T4O391P5Y

subject_name: Vactosertib

object_name: dermoid cyst


subject: CHEBI:109549

subject_name: Ramelteon

object_name: schizophrenia


subject: CHEBI:109549

object_name: schizoaffective disorder


subject: CHEBI:109549

object_name: schizophrenia 18


subject: CHEBI:109549

object_name: schizophreniform disorder


subject: DRUGBANK:DB11333

subject_name: Poloxamer 188

object_name: sickle cell disease


subject: DRUGBANK:DB11333

object_name: Vaso-Occlusive Crisis


subject: CHEBI:45783

subject_name: Imatinib

object_name: Primary malignant neoplasm


subject: CHEBI:45783

object_name: cancer


subject: CHEBI:45783

object_name: childhood malignant neoplasm


subject: CHEBI:45783

object_name: Malignant obstetric neoplasm


subject: CHEBI:45783

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1721308

object_name: asthma


subject: CHEBI:62466

subject_name: Prolycopene

object_name: prostate adenocarcinoma


subject: CHEBI:15948

subject_name: Lycopene


subject: CHEBI:94781

object_name: alcohol withdrawal


subject: CHEBI:94781

object_name: alcohol abuse


subject: CHEBI:94781

object_name: alcohol dependence


subject: CHEBI:3611

subject_name: Chlordiazepoxide


subject: CHEBI:3611


subject: CHEBI:3611


subject: CHEBI:28072

object_name: carcinoma of biliary tract


subject: CHEBI:70744

subject_name: Gly-Pro


subject: UniProtKB:P08668

subject_name: GP_HANTV Envelopment polyprotein (sprot)


subject: UniProtKB:P27312

subject_name: GP_PUUMS Envelopment polyprotein (sprot)


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IIIB Prostate Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIC Prostate Cancer AJCC v8


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: psoriasis 14, pustular


subject: PUBCHEM.COMPOUND:138713709

object_name: pustulosis palmaris et plantaris


subject: CHEBI:72296

subject_name: Apixaban

object_name: thrombophilia due to thrombin defect


subject: CHEBI:72296

object_name: Venous thrombosis after immobility


subject: UMLS:C1578240

subject_name: solfenacin

object_name: Urinary Urgency


subject: CHEBI:71940

subject_name: Tadalafil


subject: CHEBI:195559

subject_name: Poziotinib

object_name: Adenocarcinoma of lung, stage IV


subject: CHEBI:195559

object_name: Adenocarcinoma of lung stage IIIB


subject: UMLS:C3888350


subject: UMLS:C3888350


subject: UMLS:C2348999

subject_name: Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine

object_name: human papilloma virus infection


subject: UMLS:C2348999

object_name: Genital warts


subject: UMLS:C2348999

object_name: cervical cancer


subject: UMLS:C2348999

object_name: cervical carcinoma


subject: UMLS:C2348999

object_name: vaginal cancer


subject: UMLS:C2348999

object_name: vaginal carcinoma


subject: UMLS:C2348999

object_name: vulva cancer


subject: UMLS:C2348999

object_name: vulva carcinoma


subject: UMLS:C1701590

object_name: HIV infection


subject: UNII:NZW2BOW35N

subject_name: ELINZANETANT

object_name: Hot Flashes, CTCAE


subject: UNII:NZW2BOW35N

object_name: Hot flashes


subject: DRUGBANK:DB18968

subject_name: Elinzanetant


subject: DRUGBANK:DB18968


subject: UMLS:C5787214


subject: UMLS:C5787214


subject: CHEBI:64073

object_name: Childhood Craniopharyngioma


subject: CHEBI:64073

object_name: craniopharyngioma


subject: CHEBI:64073

object_name: Adult Craniopharyngioma


subject: CHEBI:64073

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:64073

object_name: obesity


subject: CHEBI:64073

object_name: Obesity, CTCAE


subject: CHEBI:64073

object_name: Overweight


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: viral disease


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: Coronavinae infectious disease


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: coronary artery disorder


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: UMLS:C0004886


subject: UMLS:C0004886


subject: UMLS:C0004886


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Waldenstrom macroglobulinemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Burkitt lymphoma


subject: CHEBI:4026

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:4026

object_name: Adult Burkitt Lymphoma


subject: CHEBI:4026

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: CHEBI:4026

object_name: primary mediastinal large B-cell lymphoma


subject: CHEBI:4026

object_name: lymphoplasmacytic lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:3367

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:3367

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: follicular lymphoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Facial Paresis


subject: CHEBI:8378

object_name: Bell's palsy


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: type 1 diabetes mellitus


subject: UNII:02DZ1HBF0M

subject_name: Emixustat

object_name: Stargardt disease


subject: CHEBI:10650

subject_name: Sumatriptan

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Arteriovenous graft site pain


subject: CHEBI:49375

subject_name: Dasatinib

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:47519

subject_name: Ketoconazole


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: Restless legs


subject: CHEBI:8356

subject_name: Pramipexole


subject: UNII:L303VER2NG

subject_name: Telcagepant Potassium

object_name: migraine


subject: UNII:L303VER2NG


subject: UMLS:C4726824


subject: UMLS:C4726824


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:73151030

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: osteoporosis


subject: CHEBI:3311

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:3311

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:3311

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:3311

object_name: acute lymphoblastic leukemia


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:U59UGK3IPC

object_name: CLL progression


subject: UNII:U59UGK3IPC

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UNII:38073MQB2A

subject_name: Umbralisib


subject: UNII:38073MQB2A


subject: UNII:38073MQB2A


subject: UMLS:C4764261

subject_name: Technetium Tc-99m Anti-HER2 Affibody ABH2

object_name: Childhood Breast Carcinoma


subject: UMLS:C4764261

object_name: breast carcinoma


subject: UMLS:C4764261

object_name: breast cancer


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Advanced breast cancer


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:3219

subject_name: Bupropion

object_name: Tabagism


subject: CHEBI:17688

subject_name: Nicotine


subject: UMLS:C2348949

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: Meniere disease


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: non-small cell lung carcinoma


subject: CHEBI:71956

subject_name: retaspimycin hydrochloride


subject: CHEBI:93755


subject: UMLS:C1708447

subject_name: IPI 504


subject: UMLS:C0293227

subject_name: Chlorotoxin

object_name: malignant glioma


subject: UMLS:C0293227

object_name: glioblastoma


subject: UMLS:C0293227

object_name: glioma susceptibility 1


subject: UMLS:C0293227

object_name: adult oligodendroglioma


subject: UMLS:C0293227

object_name: oligodendroglioma


subject: UMLS:C0293227

object_name: childhood oligodendroglioma


subject: UMLS:C0293227

object_name: Brain Stem Glioblastoma


subject: UMLS:C0293227

object_name: Childhood Astrocytoma


subject: UMLS:C0293227

object_name: astrocytic tumor


subject: UMLS:C0293227

object_name: astrocytoma


subject: UNII:6897GXD6OE

object_name: anemia


subject: UNII:6897GXD6OE

object_name: Anemia, CTCAE


subject: UNII:6897GXD6OE

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: UNII:6897GXD6OE

object_name: colorectal neoplasm


subject: CHEBI:617099

subject_name: Carbimazole

object_name: hyperthyroidism


subject: CHEBI:617099

object_name: Hyperthyroidism, CTCAE


subject: CHEBI:3490


subject: CHEBI:3490


subject: CHEBI:3489

subject_name: Cefmetazole


subject: CHEBI:3489


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: post-traumatic stress disorder


subject: CHEBI:8707

subject_name: Quetiapine


subject: CHEBI:52717

subject_name: Bortezomib

object_name: primary systemic amyloidosis


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:367163

subject_name: Darunavir

object_name: Pregnant


subject: CHEBI:367163

object_name: HIV infection


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat


subject: PUBCHEM.COMPOUND:24950485


subject: CHEBI:73629

subject_name: Phe-Asp-Cys


subject: CHEBI:73629


subject: CHEBI:38848

subject_name: perflunafene


subject: CHEBI:38848


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: PR:000001881


subject: CHEBI:63589

subject_name: Etravirine


subject: CHEBI:63589


subject: CHEBI:68606

subject_name: Rilpivirine


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: preeclampsia


subject: CHEBI:36005

object_name: Premature birth


subject: CHEBI:36005

object_name: premature birth (history)


subject: CHEBI:36005

object_name: fetal growth restriction


subject: CHEBI:36005

object_name: Fetal Growth Retardation, CTCAE


subject: CHEBI:36005

object_name: abortion


subject: CHEBI:36005

object_name: Fetal Death


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: UNII:1B8447E7YI

subject_name: CLOMIPHENE CITRATE


subject: UNII:1B8447E7YI

object_name: Unexplained infertility


subject: CHEBI:3752

subject_name: Clomifene


subject: CHEBI:3752


subject: CHEBI:81569

subject_name: Follitropin


subject: CHEBI:81569


subject: UMLS:C0016774

subject_name: Human Follicle-Stimulating Hormone


subject: UMLS:C0016774


subject: UMLS:C0018061

subject_name: Gonadotropins


subject: UMLS:C0018061


subject: UMLS:C3536870

subject_name: Gonadotropin [EPC]


subject: UMLS:C3536870


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor


subject: CHEBI:50790


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C0593802


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: asthma


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: typhoid fever


subject: UNII:6GNT3Y5LMF

object_name: Fever


subject: UNII:6GNT3Y5LMF

object_name: Fever symptoms (finding)


subject: UNII:6GNT3Y5LMF

object_name: Fever, CTCAE


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: CHEBI:100241


subject: CHEBI:100241


subject: CHEBI:60056

object_name: cocaine abuse


subject: CHEBI:27958

subject_name: Cocaine


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: no feeling or sensation of skin


subject: CHEBI:41879

object_name: Sensory Loss


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:15365

subject_name: Aspirin

object_name: coronary artery disorder


subject: CHEBI:15365

object_name: coronary atherosclerosis


subject: CHEBI:15365

object_name: Platelet aggregation test result


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: triple-negative breast carcinoma


subject: CHEBI:4026

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:4026

object_name: Stomach cancer


subject: CHEBI:4026

object_name: gastric cancer


subject: CHEBI:4026

object_name: pediatric osteosarcoma


subject: CHEBI:4026

object_name: Osteosarcoma


subject: CHEBI:4026

object_name: liver carcinoma


subject: CHEBI:4026

object_name: non-small cell lung carcinoma


subject: CHEBI:4026

object_name: malignant epithelial tumor of ovary


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:3367

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: Genital warts


subject: UMLS:C1512511

object_name: cervical cancer


subject: UMLS:C1512511

object_name: cervical intraepithelial neoplasia


subject: UMLS:C1512511

object_name: human papilloma virus infection


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: eosinophilic granulomatosis with polyangiitis


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:66964

subject_name: Dronabinol

object_name: cannabis abuse


subject: CHEBI:81686

subject_name: Magnesium L-ascorbic acid-2-phosphate

object_name: Atopic rhinitis


subject: CHEBI:81686

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:28055

subject_name: aminoparathion


subject: CHEBI:28055


subject: CHEBI:155848

subject_name: Ala-Pro


subject: CHEBI:155848


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:28971


subject: UMLS:C0002059

subject_name: Alkaline Phosphatase


subject: UMLS:C0002059


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: myocardial ischemia


subject: CHEBI:85078

object_name: Family history of ischemic heart disease


subject: CHEBI:135285

subject_name: Vildagliptin


subject: CHEBI:135285


subject: GTOPDB:8088

subject_name: epratuzumab

object_name: adult lymphoma


subject: GTOPDB:8088

object_name: lymphoma


subject: GTOPDB:8088

object_name: pediatric lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108404

subject_name: EPRATUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2108404


subject: CHEMBL.COMPOUND:CHEMBL2108404


subject: UMLS:C0281743


subject: UMLS:C0281743


subject: UMLS:C0281743


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: rectal carcinoma


subject: UNII:52CMI0WC3Y

object_name: rectal cancer


subject: UNII:52CMI0WC3Y

object_name: Childhood Rectal Carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Hyperhidrosis, CTCAE


subject: CHEBI:3160

object_name: Hyperhidrosis


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Hot Flashes, CTCAE


subject: CHEBI:50275

object_name: Hot flashes


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: malignant epithelial tumor of ovary


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: peritoneum cancer


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: fallopian tube carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: fallopian tube cancer


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Sensory Loss


subject: CHEBI:6149

subject_name: Levobupivacaine


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: chronic myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: Myelodysplasia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: UMLS:C5907992

subject_name: Lacutoclax


subject: UMLS:C5907992


subject: UMLS:C5907992


subject: UMLS:C5907992

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5907992

object_name: acute myeloid leukemia


subject: CHEBI:17334

subject_name: penicillin

object_name: syphilis


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: alveolar soft part sarcoma


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:94782

subject_name: Cediranib


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:10033

subject_name: Warfarin


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:63791

object_name: Chronic lymphocytic leukaemia stage 3


subject: GTOPDB:13828

object_name: non-small cell lung carcinoma


subject: UNII:T1JP1KYU9O

subject_name: Flortaucipir F-18

object_name: Alzheimer disease


subject: GTOPDB:13796

subject_name: serplulimab


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:135515

subject_name: Bendamustine


subject: CHEBI:31355

subject_name: Carboplatin


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:176724

subject_name: Etiracetam


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:6121

subject_name: Ketamine

object_name: Cognitive impairment


subject: CHEBI:6121

object_name: Depressive Symptoms


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: UNII:3GFS72WN4M

subject_name: ANTI-GD2 MONOCLONAL ANTIBODY 3F8

object_name: Childhood Neuroblastoma


subject: UNII:3GFS72WN4M

object_name: neuroblastoma


subject: UMLS:C0280849

subject_name: monoclonal antibody 3F8


subject: UMLS:C0280849


subject: GTOPDB:4942

subject_name: GM-CSF


subject: GTOPDB:4942


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: CHEBI:229212

subject_name: Pirtobrutinib

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:229212

object_name: lymphoid leukemia


subject: CHEBI:229212

object_name: B-Cell Leukemia


subject: CHEBI:35940

subject_name: Protirelin

object_name: chronic kidney disease


subject: CHEBI:35940

object_name: Chronic uremia


subject: CHEBI:42944

subject_name: Galantamine

object_name: schizophrenia


subject: CHEBI:42944

object_name: schizoaffective disorder


subject: CHEBI:42944

object_name: schizophrenia 18


subject: CHEBI:2453

subject_name: Acyclovir

object_name: chronic progressive multiple sclerosis


subject: CHEBI:4464

subject_name: Dexchlorpheniramine


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2698851

subject_name: POMx

object_name: cardiomyopathy


subject: UMLS:C2698851

object_name: heart failure


subject: UMLS:C2698851

object_name: Heart Failure, CTCAE


subject: CHEBI:7862

subject_name: Oxymetazoline

object_name: Mouth Breathing


subject: MESH:C000615519

object_name: Childhood Breast Carcinoma


subject: MESH:C000615519

object_name: breast cancer


subject: CHEBI:33353

subject_name: technetium atom


subject: CHEBI:33353


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:5778

object_name: congestive heart failure


subject: CHEBI:64354

subject_name: Metolazone


subject: CHEBI:64354


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Plasma cell myeloma recurrent


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:72690

subject_name: Pomalidomide


subject: PUBCHEM.COMPOUND:11422859

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:11422859

object_name: acute myeloid leukemia


subject: CHEBI:91464


subject: CHEBI:91464


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:63452


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: lung cancer


subject: CHEBI:8228

object_name: lung neoplasm


subject: CHEBI:8228

object_name: lung carcinoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: esophageal squamous cell carcinoma


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: CHEBI:600103

subject_name: daptomycin

object_name: Soft Tissue Infection


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Hypoventilation


subject: CHEBI:4466

object_name: Drug-induced hypotension


subject: CHEBI:4466

object_name: Bradycardia by ECG Finding


subject: CHEBI:4466

object_name: Bradycardia


subject: CHEBI:4466

object_name: Hypoxemia


subject: CHEBI:4466

object_name: Blood oxygen concentration below reference range (finding)


subject: UMLS:C1675748

object_name: Solid Neoplasm


subject: CHEBI:88249

subject_name: Mirdametinib


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: carpal tunnel syndrome 1


subject: CHEBI:28911

object_name: carpal tunnel syndrome


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Recurrent pterygium


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: PUBCHEM.COMPOUND:78080258

subject_name: Odalasvir

object_name: kidney failure


subject: CHEBI:59527

object_name: migraine


subject: CHEBI:59527

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: CHEBI:63631

subject_name: Topiramate


subject: CHEBI:63631


subject: CHEBI:63115

subject_name: Fingolimod

object_name: relapsing-remitting multiple sclerosis


subject: PUBCHEM.COMPOUND:2269

object_name: tuberculosis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:87715

subject_name: Prasugrel

object_name: coronary artery disorder


subject: CHEBI:87715

object_name: coronary atherosclerosis


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Diabetic foot ulcer


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Cirrhosis


subject: CHEBI:40279

object_name: liver cirrhosis


subject: UMLS:C2930749

subject_name: Radiographic contrast media

object_name: Acute Stroke


subject: CHEBI:133833

subject_name: Benznidazole

object_name: Chagas disease


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Heart failure NYHA class IV


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Asthmatic pulmonary eosinophilia


subject: UMLS:C5203460

subject_name: Cyclosporine Liquid Injection

object_name: Acute ulcerative colitis


subject: CHEBI:4031

subject_name: Cyclosporine


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Progesterone Receptor Positive


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:135565596

object_name: Estrogen Receptor Positive


subject: PUBCHEM.COMPOUND:135565596

object_name: HER2/Neu Negative


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Myelodysplasia


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: anemia


subject: UMLS:C0013227

object_name: Anemia, CTCAE


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:114785

subject_name: Erlotinib

object_name: carcinoma of esophagus


subject: CHEBI:114785

object_name: esophageal cancer


subject: CHEBI:114785

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:114785

object_name: neoplasm of esophagus


subject: CHEBI:114785

object_name: Stomach cancer


subject: CHEBI:114785

object_name: gastric cancer


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: heart failure


subject: CHEBI:192614

object_name: Heart Failure, CTCAE


subject: CHEBI:192614

object_name: pulmonary hypertension


subject: CHEBI:192614

object_name: Pulmonary Hypertension, CTCAE


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: ankle injury


subject: CHEBI:3215

subject_name: Bupivacaine


subject: PUBCHEM.COMPOUND:2367

subject_name: Betnesol


subject: CHEBI:3077

subject_name: Betamethasone


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: Cirrhosis


subject: MESH:D012462

object_name: liver cirrhosis


subject: MESH:D012462

object_name: Ascites


subject: MESH:D012462

object_name: Ascites, CTCAE


subject: CHEBI:31347

subject_name: camostat mesylate


subject: UMLS:C0108225

subject_name: Camostat mesylate


subject: MESH:C000620234

object_name: squamous cell neoplasm


subject: CHEBI:75830

subject_name: HOME

object_name: Ruptured Appendicitis


subject: UMLS:C2095775

subject_name: ampicillins


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Cervix carcinoma recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Cervical carcinoma stage IVA


subject: PUBCHEM.COMPOUND:2767

object_name: Cervical carcinoma stage IVB


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Vaginal cancer recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVA vaginal cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Vaginal Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Vaginal Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage III vaginal cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Vaginal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Vaginal Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Vulvar Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Ovarian cancer stage IV


subject: PUBCHEM.COMPOUND:2767

object_name: FIGO Stage IIIC Ovarian Cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Ovarian Cancer


subject: PUBCHEM.COMPOUND:2767

object_name: stage IIIB ovarian epithelial cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: FIGO Stage IIIA Ovarian Cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Vulvar Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Vulvar Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Vulvar Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Vulvar Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Vulvar Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Vulvar Cancer AJCC v8


subject: CHEBI:231347

subject_name: Triapine

object_name: Cervix carcinoma recurrent


subject: CHEBI:231347

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Cervical carcinoma stage IVA


subject: CHEBI:231347

object_name: Cervical carcinoma stage IVB


subject: CHEBI:231347

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:231347

object_name: Vaginal cancer recurrent


subject: CHEBI:231347

object_name: Stage IIIB Cervical Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IIIA Cervical Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: stage IVA vaginal cancer


subject: CHEBI:231347

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IVA Vaginal Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IVB Vaginal Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: stage III vaginal cancer


subject: CHEBI:231347

object_name: Stage III Vaginal Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage III Vaginal Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Recurrent Vulvar Carcinoma


subject: CHEBI:231347

object_name: Recurrent ovarian cancer


subject: CHEBI:231347

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Ovarian cancer stage IV


subject: CHEBI:231347

object_name: FIGO Stage IIIC Ovarian Cancer


subject: CHEBI:231347

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:231347

object_name: stage IIIB ovarian epithelial cancer


subject: CHEBI:231347

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: FIGO Stage IIIA Ovarian Cancer


subject: CHEBI:231347

object_name: Stage IIIC Vulvar Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IIIC Vulvar Cancer AJCC v7


subject: CHEBI:231347

object_name: Stage IIIA Vulvar Cancer AJCC v7


subject: CHEBI:231347

object_name: Stage IIIA Vulvar Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IIIB Vulvar Cancer AJCC v7


subject: CHEBI:231347

object_name: Stage IIIB Vulvar Cancer AJCC v8


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Reperfusion Injury


subject: CHEBI:40279

object_name: fetal hypoxia


subject: MESH:C000627108

object_name: amyotrophic lateral sclerosis


subject: UMLS:C4705670


subject: CHEBI:94366

subject_name: itraconazole

object_name: childhood malignant neoplasm


subject: UMLS:C5854457

subject_name: Anti-PD-1/Anti-ILT4 Bispecific Antibody CDX-585

object_name: Neck Carcinoma


subject: UMLS:C5854457

object_name: head and neck neoplasm


subject: UMLS:C5854457

object_name: head and neck cancer


subject: UMLS:C5854457

object_name: bladder transitional cell carcinoma


subject: UMLS:C5854457

object_name: transitional cell carcinoma


subject: UMLS:C5854457

object_name: primary peritoneal carcinoma


subject: UMLS:C5854457

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C5854457

object_name: peritoneal carcinoma


subject: UMLS:C5854457

object_name: non-small cell lung carcinoma


subject: UMLS:C5854457

object_name: fallopian tube carcinoma


subject: UMLS:C5854457

object_name: fallopian tube cancer


subject: UMLS:C5854457

object_name: liver cancer


subject: UMLS:C5854457

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5854457

object_name: clear cell renal carcinoma


subject: UMLS:C5854457

object_name: renal cell adenocarcinoma


subject: UMLS:C5854457

object_name: renal cell carcinoma


subject: UMLS:C5854457

object_name: pancreatic neoplasm


subject: UMLS:C5854457

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5854457

object_name: malignant pancreatic neoplasm


subject: UMLS:C5854457

object_name: carcinoma of esophagus


subject: UMLS:C5854457

object_name: esophageal cancer


subject: UMLS:C5854457

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5854457

object_name: neoplasm of esophagus


subject: UMLS:C5854457

object_name: colorectal cancer


subject: UMLS:C5854457

object_name: colorectal carcinoma


subject: UMLS:C5854457

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5854457

object_name: cholangiocarcinoma


subject: UMLS:C5854457

object_name: ovarian cancer


subject: UMLS:C5854457

object_name: ovarian neoplasm


subject: UMLS:C5854457

object_name: ovarian carcinoma


subject: UMLS:C5854457

object_name: Stomach cancer


subject: UMLS:C5854457

object_name: gastric cancer


subject: UMLS:C5854457

object_name: liver carcinoma


subject: DRUGBANK:DB17107

subject_name: Lifileucel

object_name: Head and neck cancer metastatic


subject: DRUGBANK:DB17107

object_name: metastatic melanoma


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: type 2 diabetes mellitus


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UNII:645R07LF0D

subject_name: Ezutromid

object_name: Duchenne muscular dystrophy


subject: MESH:C000610115

subject_name: SMT C1100


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: PUBCHEM.COMPOUND:521372

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:521372

object_name: breast carcinoma


subject: CHEBI:183415


subject: CHEBI:183415


subject: CHEBI:183415


subject: UNII:WO23I2827Q

object_name: osteoarthritis


subject: CHEBI:51098

subject_name: Motesanib

object_name: adult lymphoma


subject: CHEBI:51098

object_name: lymphoma


subject: CHEBI:51098

object_name: pediatric lymphoma


subject: CHEBI:51098

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2107856

subject_name: IMETELSTAT


subject: CHEMBL.COMPOUND:CHEMBL2107856


subject: CHEMBL.COMPOUND:CHEMBL2107856


subject: CHEMBL.COMPOUND:CHEMBL2107856


subject: UNII:F60NE4XB53

subject_name: imetelstat


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: CHEBI:71219

subject_name: Pazopanib


subject: CHEBI:71219


subject: UMLS:C5418027


subject: UMLS:C5544102


subject: UMLS:C0939844

subject_name: red clover preparation

object_name: Urinary Urgency


subject: UMLS:C0939844

object_name: urgency urinary incontinence


subject: UniProtKB:Q99RL2

subject_name: SBI_STAAN Immunoglobulin-binding protein Sbi (sprot)

object_name: pouchitis


subject: UniProtKB:Q8NV09

subject_name: SBI_STAAW Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q5HDD7

subject_name: SBI_STAAC Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q6G6Q3

subject_name: SBI_STAAS Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:A6QJQ7

subject_name: SBI_STAAE Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q6GE15

subject_name: SBI_STAAR Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:A6U4E8

subject_name: SBI_STAA2 Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q2FE79

subject_name: SBI_STAA3 Immunoglobulin-binding protein Sbi (sprot)


subject: UMLS:C3896610

subject_name: Serum-derived Bovine Immunoglobulin Protein Isolate


subject: UniProtKB:A5IVJ8

subject_name: SBI_STAA9 Immunoglobulin-binding protein Sbi (sprot)


subject: PR:000024853

subject_name: immunoglobulin-binding protein Sbi


subject: UniProtKB:A8YYG7

subject_name: SBI_STAAT Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q2YVZ4

subject_name: SBI_STAAB Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:A7X659

subject_name: SBI_STAA1 Immunoglobulin-binding protein Sbi (sprot)


subject: UniProtKB:Q931F4

subject_name: SBI_STAAM Immunoglobulin-binding protein Sbi (sprot)


subject: UMLS:C5966113

subject_name: CDK8/19 Inhibitor RVU120

object_name: childhood acute myeloid leukemia


subject: UMLS:C5966113

object_name: acute myeloid leukemia


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Deep vein thrombosis of lower limb


subject: MESH:D006495

object_name: Deep venous thrombosis


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Nephrotic syndrome in children


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:135920

subject_name: Fesoterodine


subject: UNII:7DP3NTV15T

subject_name: BLEOMYCIN SULFATE

object_name: Childhood Extracranial Germ Cell Tumor


subject: UNII:7DP3NTV15T

object_name: Childhood Extragonadal Malignant Germ Cell Tumor


subject: UNII:7DP3NTV15T

object_name: Childhood Teratoma


subject: UNII:7DP3NTV15T

object_name: Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: stage IIB ovarian germ cell tumor


subject: UNII:7DP3NTV15T

object_name: Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: stage IIIB ovarian germ cell tumor


subject: UNII:7DP3NTV15T

object_name: Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: stage IIIA ovarian germ cell tumor


subject: UNII:7DP3NTV15T

object_name: Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: stage IIIC ovarian germ cell tumor


subject: UNII:7DP3NTV15T

object_name: Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: Childhood Malignant Ovarian Germ Cell Tumor


subject: UNII:7DP3NTV15T

object_name: childhood embryonal tumor


subject: UNII:7DP3NTV15T

object_name: Childhood Malignant Testicular Germ Cell Tumor


subject: UNII:7DP3NTV15T

object_name: stage III testicular cancer


subject: UNII:7DP3NTV15T

object_name: stage II testicular cancer


subject: UNII:7DP3NTV15T

object_name: Testicular Mixed Choriocarcinoma and Yolk Sac Tumor


subject: UNII:7DP3NTV15T

object_name: ovarian yolk sac tumor


subject: UNII:7DP3NTV15T

object_name: testicular embryonal carcinoma


subject: UNII:7DP3NTV15T

object_name: ovarian embryonal carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Childhood Extracranial Germ Cell Tumor


subject: PUBCHEM.COMPOUND:2767

object_name: Childhood Extragonadal Malignant Germ Cell Tumor


subject: PUBCHEM.COMPOUND:2767

object_name: Childhood Teratoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IIB ovarian germ cell tumor


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IIIB ovarian germ cell tumor


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IIIA ovarian germ cell tumor


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IIIC ovarian germ cell tumor


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Childhood Malignant Ovarian Germ Cell Tumor


subject: PUBCHEM.COMPOUND:2767

object_name: childhood embryonal tumor


subject: PUBCHEM.COMPOUND:2767

object_name: Childhood Malignant Testicular Germ Cell Tumor


subject: PUBCHEM.COMPOUND:2767

object_name: stage III testicular cancer


subject: PUBCHEM.COMPOUND:2767

object_name: stage II testicular cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular Mixed Choriocarcinoma and Yolk Sac Tumor


subject: PUBCHEM.COMPOUND:2767

object_name: ovarian yolk sac tumor


subject: PUBCHEM.COMPOUND:2767

object_name: testicular embryonal carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: ovarian embryonal carcinoma


subject: CHEBI:4911

subject_name: Etoposide

object_name: Childhood Extracranial Germ Cell Tumor


subject: CHEBI:4911

object_name: Childhood Extragonadal Malignant Germ Cell Tumor


subject: CHEBI:4911

object_name: Childhood Teratoma


subject: CHEBI:4911

object_name: Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:4911

object_name: Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:4911

object_name: stage IIB ovarian germ cell tumor


subject: CHEBI:4911

object_name: Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:4911

object_name: stage IIIB ovarian germ cell tumor


subject: CHEBI:4911

object_name: Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:4911

object_name: stage IIIA ovarian germ cell tumor


subject: CHEBI:4911

object_name: Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:4911

object_name: stage IIIC ovarian germ cell tumor


subject: CHEBI:4911

object_name: Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:4911

object_name: Childhood Malignant Ovarian Germ Cell Tumor


subject: CHEBI:4911

object_name: childhood embryonal tumor


subject: CHEBI:4911

object_name: Childhood Malignant Testicular Germ Cell Tumor


subject: CHEBI:4911

object_name: stage III testicular cancer


subject: CHEBI:4911

object_name: stage II testicular cancer


subject: CHEBI:4911

object_name: Testicular Mixed Choriocarcinoma and Yolk Sac Tumor


subject: CHEBI:4911

object_name: ovarian yolk sac tumor


subject: CHEBI:4911

object_name: testicular embryonal carcinoma


subject: CHEBI:4911

object_name: ovarian embryonal carcinoma


subject: CHEBI:3139

subject_name: bleomycin

object_name: Childhood Extracranial Germ Cell Tumor


subject: CHEBI:3139

object_name: Childhood Extragonadal Malignant Germ Cell Tumor


subject: CHEBI:3139

object_name: Childhood Teratoma


subject: CHEBI:3139

object_name: Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:3139

object_name: Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:3139

object_name: stage IIB ovarian germ cell tumor


subject: CHEBI:3139

object_name: Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:3139

object_name: stage IIIB ovarian germ cell tumor


subject: CHEBI:3139

object_name: Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:3139

object_name: stage IIIA ovarian germ cell tumor


subject: CHEBI:3139

object_name: Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:3139

object_name: stage IIIC ovarian germ cell tumor


subject: CHEBI:3139

object_name: Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:3139

object_name: Childhood Malignant Ovarian Germ Cell Tumor


subject: CHEBI:3139

object_name: childhood embryonal tumor


subject: CHEBI:3139

object_name: Childhood Malignant Testicular Germ Cell Tumor


subject: CHEBI:3139

object_name: stage III testicular cancer


subject: CHEBI:3139

object_name: stage II testicular cancer


subject: CHEBI:3139

object_name: Testicular Mixed Choriocarcinoma and Yolk Sac Tumor


subject: CHEBI:3139

object_name: ovarian yolk sac tumor


subject: CHEBI:3139

object_name: testicular embryonal carcinoma


subject: CHEBI:3139

object_name: ovarian embryonal carcinoma


subject: UMLS:C0885467

subject_name: Juglans regia preparation

object_name: cardiovascular disorder


subject: UMLS:C3813211

subject_name: Prostaglandin E2

object_name: previous induced delivery


subject: CHEBI:15551

subject_name: Dinoprostone


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C2348288

object_name: amyotrophic lateral sclerosis


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: CHEMBL.COMPOUND:CHEMBL55643

subject_name: COPPER


subject: CHEMBL.COMPOUND:CHEMBL55643


subject: CHEBI:28694

subject_name: Copper


subject: CHEBI:28694


subject: CHEBI:29036

subject_name: Cupric cation


subject: CHEBI:29036


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3827082


subject: UMLS:C5444544

subject_name: black tea


subject: UNII:I3P9R8317T

subject_name: phenolic acid


subject: CHEBI:135782

subject_name: ulobetasol propionate

object_name: Chronic small plaque psoriasis


subject: UMLS:C0723213

subject_name: Santyl

object_name: Diabetic foot ulcer


subject: UMLS:C0722264

subject_name: Ontak

object_name: ovarian carcinoma


subject: UMLS:C0722264

object_name: malignant epithelial tumor of ovary


subject: UMLS:C0722264

object_name: fallopian tube carcinoma


subject: CHEBI:229233

subject_name: Ritlecitinib

object_name: kidney failure


subject: CHEBI:28918

subject_name: Epinephrine

object_name: post operative nausea and vomiting


subject: CHEBI:194548

subject_name: Racepinephrine

object_name: Post-Operative Pain


subject: CHEBI:194548


subject: CHEBI:6149

subject_name: Levobupivacaine


subject: CHEBI:6149


subject: PUBCHEM.COMPOUND:84036

subject_name: Aldoxorubicin

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:3367

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C4520835

subject_name: Factor viii (antihemophilic factor, human) per i.u.

object_name: Congenital Bleeding Disorder


subject: UMLS:C0700346

subject_name: Koate-DVI


subject: UMLS:C2726511

subject_name: Wilate


subject: UMLS:C4718976

subject_name: Beroctocog alfa


subject: UMLS:C0015506

subject_name: factor VIII


subject: CHEMBL.COMPOUND:CHEMBL2108455

subject_name: octocog alfa

object_name: hemophilia A


subject: CHEMBL.COMPOUND:CHEMBL2108455


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Traumatic Wound


subject: CHEBI:38290

object_name: Injury


subject: CHEBI:38290

object_name: Wounds and Injuries


subject: CHEBI:38290

object_name: Fractured mandible


subject: CHEBI:38290

object_name: scurvy


subject: CHEBI:38290

object_name: Open fracture of mandible


subject: CHEBI:38290

object_name: Fracture of mandible, closed


subject: CHEBI:38290

object_name: Cutaneous wound


subject: CHEBI:38290

object_name: Wound Infection


subject: CHEBI:38290

object_name: Wound Infection, CTCAE


subject: CHEBI:38290

object_name: Wound dehiscence


subject: CHEBI:38290

object_name: Wound Dehiscence, CTCAE


subject: CHEBI:38290

object_name: Wound Complication


subject: CHEBI:38290

object_name: Wound Complication, CTCAE


subject: CHEBI:38290

object_name: Surgery--Complications


subject: CHEBI:38290

object_name: Increased reactive oxygen species production


subject: CHEBI:38290

object_name: Inflammation


subject: CHEBI:38290

object_name: Surgical procedure finding


subject: CHEBI:176783

subject_name: vitamin C

object_name: Traumatic Wound


subject: CHEBI:176783

object_name: Injury


subject: CHEBI:176783

object_name: Wounds and Injuries


subject: CHEBI:176783

object_name: Fractured mandible


subject: CHEBI:176783

object_name: scurvy


subject: CHEBI:176783

object_name: Open fracture of mandible


subject: CHEBI:176783

object_name: Fracture of mandible, closed


subject: CHEBI:176783

object_name: Cutaneous wound


subject: CHEBI:176783

object_name: Wound Infection


subject: CHEBI:176783

object_name: Wound Infection, CTCAE


subject: CHEBI:176783

object_name: Wound dehiscence


subject: CHEBI:176783

object_name: Wound Dehiscence, CTCAE


subject: CHEBI:176783

object_name: Wound Complication


subject: CHEBI:176783

object_name: Wound Complication, CTCAE


subject: CHEBI:176783

object_name: Surgery--Complications


subject: CHEBI:176783

object_name: Increased reactive oxygen species production


subject: CHEBI:176783

object_name: Inflammation


subject: CHEBI:176783

object_name: Surgical procedure finding


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class

object_name: Traumatic Wound


subject: UMLS:C3714687

object_name: Injury


subject: UMLS:C3714687

object_name: Wounds and Injuries


subject: UMLS:C3714687

object_name: Fractured mandible


subject: UMLS:C3714687

object_name: scurvy


subject: UMLS:C3714687

object_name: Open fracture of mandible


subject: UMLS:C3714687

object_name: Fracture of mandible, closed


subject: UMLS:C3714687

object_name: Cutaneous wound


subject: UMLS:C3714687

object_name: Wound Infection


subject: UMLS:C3714687

object_name: Wound Infection, CTCAE


subject: UMLS:C3714687

object_name: Wound dehiscence


subject: UMLS:C3714687

object_name: Wound Dehiscence, CTCAE


subject: UMLS:C3714687

object_name: Wound Complication


subject: UMLS:C3714687

object_name: Wound Complication, CTCAE


subject: UMLS:C3714687

object_name: Surgery--Complications


subject: UMLS:C3714687

object_name: Increased reactive oxygen species production


subject: UMLS:C3714687

object_name: Inflammation


subject: UMLS:C3714687

object_name: Surgical procedure finding


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins

object_name: Traumatic Wound


subject: UMLS:C2349136

object_name: Injury


subject: UMLS:C2349136

object_name: Wounds and Injuries


subject: UMLS:C2349136

object_name: Fractured mandible


subject: UMLS:C2349136

object_name: scurvy


subject: UMLS:C2349136

object_name: Open fracture of mandible


subject: UMLS:C2349136

object_name: Fracture of mandible, closed


subject: UMLS:C2349136

object_name: Cutaneous wound


subject: UMLS:C2349136

object_name: Wound Infection


subject: UMLS:C2349136

object_name: Wound Infection, CTCAE


subject: UMLS:C2349136

object_name: Wound dehiscence


subject: UMLS:C2349136

object_name: Wound Dehiscence, CTCAE


subject: UMLS:C2349136

object_name: Wound Complication


subject: UMLS:C2349136

object_name: Wound Complication, CTCAE


subject: UMLS:C2349136

object_name: Surgery--Complications


subject: UMLS:C2349136

object_name: Increased reactive oxygen species production


subject: UMLS:C2349136

object_name: Inflammation


subject: UMLS:C2349136

object_name: Surgical procedure finding


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Traumatic Wound


subject: CHEBI:22652

object_name: Injury


subject: CHEBI:22652

object_name: Wounds and Injuries


subject: CHEBI:22652

object_name: Fractured mandible


subject: CHEBI:22652

object_name: scurvy


subject: CHEBI:22652

object_name: Open fracture of mandible


subject: CHEBI:22652

object_name: Fracture of mandible, closed


subject: CHEBI:22652

object_name: Cutaneous wound


subject: CHEBI:22652

object_name: Wound Infection


subject: CHEBI:22652

object_name: Wound Infection, CTCAE


subject: CHEBI:22652

object_name: Wound dehiscence


subject: CHEBI:22652

object_name: Wound Dehiscence, CTCAE


subject: CHEBI:22652

object_name: Wound Complication


subject: CHEBI:22652

object_name: Wound Complication, CTCAE


subject: CHEBI:22652

object_name: Surgery--Complications


subject: CHEBI:22652

object_name: Increased reactive oxygen species production


subject: CHEBI:22652

object_name: Inflammation


subject: CHEBI:22652

object_name: Surgical procedure finding


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]

object_name: Traumatic Wound


subject: UMLS:C4522080

object_name: Injury


subject: UMLS:C4522080

object_name: Wounds and Injuries


subject: UMLS:C4522080

object_name: Fractured mandible


subject: UMLS:C4522080

object_name: scurvy


subject: UMLS:C4522080

object_name: Open fracture of mandible


subject: UMLS:C4522080

object_name: Fracture of mandible, closed


subject: UMLS:C4522080

object_name: Cutaneous wound


subject: UMLS:C4522080

object_name: Wound Infection


subject: UMLS:C4522080

object_name: Wound Infection, CTCAE


subject: UMLS:C4522080

object_name: Wound dehiscence


subject: UMLS:C4522080

object_name: Wound Dehiscence, CTCAE


subject: UMLS:C4522080

object_name: Wound Complication


subject: UMLS:C4522080

object_name: Wound Complication, CTCAE


subject: UMLS:C4522080

object_name: Surgery--Complications


subject: UMLS:C4522080

object_name: Increased reactive oxygen species production


subject: UMLS:C4522080

object_name: Inflammation


subject: UMLS:C4522080

object_name: Surgical procedure finding


subject: CHEBI:83527

subject_name: Desvenlafaxine

object_name: endogenous depression


subject: CHEBI:83527

object_name: major depressive disorder


subject: GTOPDB:12989

subject_name: toripalimab

object_name: non-small cell lung carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:8499

subject_name: Propranolol

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:6801

subject_name: Metformin

object_name: Androgen excess


subject: CHEBI:6801

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:6801

object_name: obesity


subject: CHEBI:6801

object_name: Obesity, CTCAE


subject: CHEBI:72296

subject_name: Apixaban

object_name: venous thromboembolism


subject: CHEBI:72296

object_name: plasma cell myeloma


subject: CHEBI:136044

subject_name: Fimasartan

object_name: essential hypertension


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Anterior chamber inflammation


subject: PUBCHEM.COMPOUND:447451

subject_name: cethromycin

object_name: pneumonia


subject: PUBCHEM.COMPOUND:447451

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:9356

subject_name: Sultopride

object_name: psychosis


subject: CHEBI:9356

object_name: schizophrenia


subject: CHEBI:64045

subject_name: Amisulpride


subject: CHEBI:64045


subject: CHEBI:229652

subject_name: Iptacopan

object_name: IgA Nephropathy


subject: CHEBI:229652

object_name: IgA nephropathy, susceptibility to, 1


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: bone cancer


subject: UMLS:C0016004

object_name: bone neoplasm


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:94518


subject: CHEBI:567361

subject_name: Cladribine

object_name: acute lymphoblastic leukemia


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: adult lymphoma


subject: CHEBI:175901

object_name: lymphoma


subject: CHEBI:175901

object_name: pediatric lymphoma


subject: CHEBI:175901

object_name: leukemia


subject: CHEBI:175901

object_name: childhood leukemia


subject: CHEBI:175901

object_name: plasma cell myeloma


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: UNII:QMS40680K6


subject: UNII:QMS40680K6


subject: UNII:QMS40680K6


subject: UNII:QMS40680K6


subject: UNII:QMS40680K6


subject: UMLS:C4307736

object_name: colorectal adenoma


subject: UMLS:C4307736

object_name: colorectal cancer


subject: UMLS:C4307736

object_name: colorectal carcinoma


subject: UMLS:C4307736

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:84883


subject: CHEBI:84883


subject: CHEBI:84883


subject: UMLS:C5555467

subject_name: Latozinemab

object_name: Alzheimer disease


subject: UMLS:C5705654


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:93755


subject: CHEBI:90943

subject_name: Osimertinib

object_name: cancer


subject: CHEBI:90943

object_name: neoplasm


subject: UNII:WKM56H3TLB

subject_name: Myrcludex B

object_name: hepatitis D


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Acute lymphoid leukemia in remission


subject: CHEBI:4026

object_name: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: precursor B-cell acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: B-cell childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: B-cell adult acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: B-cell acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:28887

subject_name: Ofatumumab


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:63630

subject_name: Tolcapone

object_name: infectious disease


subject: CHEBI:36796

subject_name: duloxetine


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: nicotine dependence


subject: CHEBI:125628

subject_name: Alisertib

object_name: adult lymphoma


subject: CHEBI:125628

object_name: lymphoma


subject: CHEBI:125628

object_name: pediatric lymphoma


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Skin Bruise


subject: CHEBI:28918

object_name: Easy Bruising


subject: CHEBI:28918

object_name: Ecchymosis


subject: CHEBI:28918

object_name: Subcutaneous hematoma


subject: CHEBI:28918

object_name: Venous insufficiency of leg


subject: CHEBI:28918

object_name: Varicose Ulcer


subject: CHEBI:28918

object_name: Venous stasis


subject: CHEBI:28918

object_name: chronic venous insufficiency


subject: CHEBI:28918

object_name: Venous reflux


subject: CHEBI:28918

object_name: vein disorder


subject: CHEBI:28918

object_name: Contusions


subject: CHEBI:28918

object_name: reported bruising (history)


subject: CHEBI:28918

object_name: Bruising, CTCAE


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: adrenal cortex carcinoma


subject: UNII:5S371K6132

object_name: adenoid cystic carcinoma


subject: UMLS:C5848169

subject_name: Nadroparin Calcium

object_name: Advanced cancer


subject: UMLS:C5848169

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5848169

object_name: Embolism, Tumor


subject: UMLS:C5848169

object_name: Neoplasm Metastasis


subject: UNII:LIA7Z4002P

subject_name: Nadroparin


subject: UNII:LIA7Z4002P


subject: UNII:LIA7Z4002P


subject: UNII:LIA7Z4002P


subject: CHEBI:84500

subject_name: varenicline

object_name: schizoaffective disorder


subject: CHEBI:84500

object_name: schizophrenia 18


subject: CHEBI:84500

object_name: tardive dyskinesia


subject: CHEBI:84500

object_name: Parkinsonism


subject: CHEBI:31348

subject_name: Capecitabine

object_name: HER2-positive gastric cancer


subject: GTOPDB:13789

subject_name: enlonstobart


subject: CHEMBL.COMPOUND:CHEMBL5315040

subject_name: ENLONSTOBART


subject: UMLS:C5557417

subject_name: Enlonstobart


subject: UMLS:C5783522

subject_name: Anti-HER2 Antibody-drug Conjugate JSKN003


subject: UMLS:C5206660

subject_name: Anbenitamab


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Neuroendocrine carcinoma of the bladder


subject: GTOPDB:13085

object_name: bladder tumor


subject: GTOPDB:13085

object_name: urinary bladder carcinoma


subject: GTOPDB:13085

object_name: urinary bladder cancer


subject: GTOPDB:13085

object_name: childhood bladder carcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: GTOPDB:13624

subject_name: inclisiran

object_name: atherosclerosis


subject: UMLS:C5854386

subject_name: Lenalidomide Prolonged-release Formulation NEX-20A

object_name: plasma cell myeloma


subject: CHEBI:77543

subject_name: Ebselen

object_name: Meniere disease


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: intrahepatic cholangiocarcinoma


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:78122784

subject_name: Tenapanor

object_name: Constipation


subject: PUBCHEM.COMPOUND:78122784

object_name: Constipation, CTCAE


subject: PUBCHEM.COMPOUND:78122784

object_name: cystic fibrosis


subject: CHEBI:6015

subject_name: Isoflurane

object_name: Sedation


subject: CHEBI:6015

object_name: Sedated


subject: UMLS:C4724802

object_name: Childhood Solid Neoplasm


subject: UMLS:C4724802

object_name: Adult Solid Neoplasm


subject: UMLS:C4724802

object_name: Solid Neoplasm


subject: UMLS:C4724802

object_name: leiomyosarcoma


subject: UMLS:C4724802

object_name: Childhood Leiomyosarcoma


subject: UMLS:C4724802

object_name: Adult Leiomyosarcoma


subject: UMLS:C4724802

object_name: pediatric osteosarcoma


subject: UMLS:C4724802

object_name: Osteosarcoma


subject: UMLS:C0225326

subject_name: fiber

object_name: Ebola hemorrhagic fever


subject: CHEBI:90227

subject_name: Selumetinib

object_name: melanoma


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: cancer


subject: UNII:5S371K6132

object_name: neoplasm


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEMBL.COMPOUND:CHEMBL3545231

object_name: schizophrenia


subject: UNII:9K8GNJ2874

subject_name: Naxitamab

object_name: High Risk Neuroblastoma


subject: UMLS:C4054758

subject_name: naxitamab


subject: CHEBI:47458

subject_name: Saracatinib

object_name: invasive malignant thymoma


subject: CHEBI:47458

object_name: Thymoma malignant recurrent


subject: CHEBI:47458

object_name: Stage III Thymoma AJCC v8


subject: CHEBI:47458

object_name: stage III thymoma


subject: CHEBI:47458

object_name: stage IVB thymoma


subject: CHEBI:47458

object_name: Stage IVB Thymoma AJCC v8


subject: CHEBI:47458

object_name: Stage IVA Thymoma AJCC v8


subject: CHEBI:47458

object_name: stage IVA thymoma


subject: UMLS:C5666876

subject_name: BRAF V600E Inhibitor HLX208

object_name: non-small cell lung carcinoma


subject: CHEBI:231614

object_name: Hodgkin Disease


subject: CHEBI:231614

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:231614

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:66919


subject: DRUGBANK:DB15483

subject_name: Modified vaccinia ankara

object_name: monkeypox


subject: UMLS:C5418138

subject_name: imvanex


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Depressed mood


subject: CHEBI:36791

object_name: Cancer patients and suicide and depression


subject: CHEBI:36791

object_name: Depressed - symptom


subject: CHEBI:36791

object_name: Depression, CTCAE


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Disorder of transplanted kidney


subject: UMLS:C5770862

subject_name: Leukocyte interleukin

object_name: Condyloma


subject: UMLS:C5770862

object_name: Genital warts


subject: CHEBI:10119

subject_name: Ziprasidone


subject: CHEBI:10119


subject: CHEBI:10119


subject: CHEBI:10119


subject: CHEBI:10119

object_name: bipolar depression


subject: CHEBI:32314

subject_name: Geodon


subject: CHEBI:32314


subject: CHEBI:32314


subject: CHEBI:32314


subject: CHEBI:32314

object_name: bipolar disorder


subject: CHEBI:32314


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Solid Neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C2986853

subject_name: Anti-human GITR Monoclonal Antibody TRX518


subject: RXCUI:1999664

subject_name: bictegravir / emtricitabine / tenofovir alafenamide Oral Product

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester

object_name: Metastatic malignant neoplasm to liver


subject: PUBCHEM.COMPOUND:3298

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:3298

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:3298

object_name: colon cancer


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:84883


subject: CHEBI:84883


subject: PR:000007084

subject_name: mitochondrial enolase superfamily member 1

object_name: malaria


subject: PR:000022308

subject_name: pantothenate kinase


subject: PR:000013861

subject_name: ATP-dependent DNA helicase Q4


subject: UniProtKB:P0A6I3

subject_name: COAA_ECOLI Pantothenate kinase (sprot)


subject: UMLS:C5238480

object_name: prostate carcinoma


subject: UMLS:C5238480

object_name: prostate cancer


subject: UMLS:C5238480

object_name: neoplasm


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

object_name: Childhood Breast Carcinoma


subject: UMLS:C3540795

object_name: breast carcinoma


subject: UMLS:C3540795

object_name: breast cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Alzheimer disease


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C2987342

object_name: lymphoma


subject: UMLS:C2987342

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: open-angle glaucoma


subject: CHEBI:73678


subject: CHEBI:28864

subject_name: Tobramycin


subject: PUBCHEM.COMPOUND:66577443

subject_name: Fluorothymidine

object_name: graft versus host disease


subject: UMLS:C4707655


subject: CHEBI:177762

subject_name: Alovudine


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1